Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis

Purpose: There is uncertainty as to which anticoagulant should be used in non-valvular atrial fibrillation (AF) with valvular heart disease. This systematic review and meta-analysis aimed to assess the efficacy and safety of direct-acting oral anticoagulants (DOACs) compared with warfarin in patient...

Full description

Bibliographic Details
Main Authors: Januar Wibawa Martha, Raymond Pranata, Wilson Matthew Raffaelo, Arief Wibowo, Mohammad Rizki Akbar
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
DOAC
direct-acting oral anticoagulant
NOAC
vitamin K antagonist (VKA)
valvular heart disease
atrial fibrillation
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.764356/full

Similar Items

Similar Items